Major molecular response achieved with dasatinib in a CML patient with F317L BCR-ABL kinase domain mutation (Q43265473)
Jump to navigation
Jump to search
scientific article published on 6 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Major molecular response achieved with dasatinib in a CML patient with F317L BCR-ABL kinase domain mutation |
scientific article published on 6 October 2009 |
Statements
1 reference
Major molecular response achieved with dasatinib in a CML patient with F317L BCR-ABL kinase domain mutation (English)
1 reference
Edgar Faber
1 reference
Renata Mojzikova
1 reference
Radek Plachy
1 reference
Sarka Rozmanova
1 reference
Marek Stastny
1 reference
Martina Divoka
1 reference
Marie Jarosova
1 reference
Karel Indrak
1 reference
Vladimir Divoky
1 reference
6 October 2009
1 reference
1 reference
34
1 reference
4
1 reference
e91-3
1 reference
Identifiers
1 reference
1 reference